Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11.

Lucs AV, DeVoti JA, Hatam L, Afzal A, Abramson AL, Steinberg BM, Bonagura VR.

J Clin Med. 2015 Mar;4(3):375-88. doi: 10.3390/jcm4030375.


Overexpressed β-catenin localizes to plasma membrane in respiratory papillomas.

Lucs AV, Abramson AL, Steinberg BM.

J Invest Dermatol. 2014 Jun;134(6):1760-1763. doi: 10.1038/jid.2014.48. Epub 2014 Jan 29. No abstract available.


T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis.

Rosenthal DW, DeVoti JA, Steinberg BM, Abramson AL, Bonagura VR.

Mol Med. 2012 Dec 6;18:1338-45. doi: 10.2119/molmed.2012.00284.


Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.

Hatam LJ, Devoti JA, Rosenthal DW, Lam F, Abramson AL, Steinberg BM, Bonagura VR.

Clin Cancer Res. 2012 Apr 1;18(7):1925-35. doi: 10.1158/1078-0432.CCR-11-2941. Epub 2012 Feb 9.


Constitutive overexpression of the oncogene Rac1 in the airway of recurrent respiratory papillomatosis patients is a targetable host-susceptibility factor.

Lucs AV, Wu R, Mullooly V, Abramson AL, Steinberg BM.

Mol Med. 2012 Mar 30;18:244-9. doi: 10.2119/molmed.2011.00447.


Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.

James EA, DeVoti JA, Rosenthal DW, Hatam LJ, Steinberg BM, Abramson AL, Kwok WW, Bonagura VR.

J Immunol. 2011 Jun 1;186(11):6633-40. doi: 10.4049/jimmunol.1004181. Epub 2011 Apr 29.


Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.

Bonagura VR, Hatam LJ, Rosenthal DW, de Voti JA, Lam F, Steinberg BM, Abramson AL.

APMIS. 2010 Jun;118(6-7):455-70. doi: 10.1111/j.1600-0463.2010.02617.x. Review.


Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1-mediated COX-2 expression.

Wu R, Abramson AL, Symons MH, Steinberg BM.

Int J Cancer. 2010 Nov 1;127(9):2230-7. doi: 10.1002/ijc.25226.


Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

Bonagura VR, Du Z, Ashouri E, Luo L, Hatam LJ, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Gjertson DW, Reed EF, Rajalingam R.

Hum Immunol. 2010 Feb;71(2):212-9. doi: 10.1016/j.humimm.2009.10.009. Epub 2009 Oct 25.


Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis.

DeVoti JA, Rosenthal DW, Wu R, Abramson AL, Steinberg BM, Bonagura VR.

Mol Med. 2008 Sep-Oct;14(9-10):608-17. doi: 10.2119/2008-00060.DeVoti.


Four mutations in Epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRP.

Donfack J, Buchinsky FJ, Derkay CS, Steinberg BM, Choi SS, Conley SF, Meyer CM 3rd, McClay JE, Campisi P, Hu FZ, Preston RA, Abramson AL, Ehrlich GD, Post JC.

Int J Pediatr Otorhinolaryngol. 2006 Jul;70(7):1235-40. Epub 2006 Feb 17.


Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis.

Shikowitz MJ, Abramson AL, Steinberg BM, DeVoti J, Bonagura VR, Mullooly V, Nouri M, Ronn AM, Inglis A, McClay J, Freeman K.

Arch Otolaryngol Head Neck Surg. 2005 Feb;131(2):99-105.


HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis.

Bonagura VR, Vambutas A, DeVoti JA, Rosenthal DW, Steinberg BM, Abramson AL, Shikowitz MJ, Gjertson DW, Reed EF.

Hum Immunol. 2004 Aug;65(8):773-82.


Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis.

DeVoti JA, Steinberg BM, Rosenthal DW, Hatam L, Vambutas A, Abramson AL, Shikowitz MJ, Bonagura VR.

Clin Diagn Lab Immunol. 2004 May;11(3):538-47.


Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11.

Vambutas A, Bonagura VR, Reed EF, Abramson AL, Mullooly V, DeVoti J, Gjertson DW, Steinberg BM.

J Infect Dis. 2004 Mar 1;189(5):871-9. Epub 2004 Feb 16.


Latent Human Papillomavirus infection is comparable in the larynx and trachea.

Abramson AL, Nouri M, Mullooly V, Fisch G, Steinberg BM.

J Med Virol. 2004 Mar;72(3):473-7.


Anterior-posterior and medial compression of the supraglottis: signs of nonorganic dysphonia or normal postures?

Behrman A, Dahl LD, Abramson AL, Schutte HK.

J Voice. 2003 Sep;17(3):403-10.


Supplemental Content

Loading ...
Support Center